PetVivo Holdings, Inc. (PETV)
| Market Cap | 38.65M |
| Revenue (ttm) | 1.41M |
| Net Income (ttm) | -9.65M |
| Shares Out | 33.91M |
| EPS (ttm) | -0.41 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 31,187 |
| Average Volume | 20,259 |
| Open | 1.060 |
| Previous Close | 1.060 |
| Day's Range | 1.030 - 1.150 |
| 52-Week Range | 0.450 - 1.690 |
| Beta | 1.16 |
| RSI | 48.58 |
| Earnings Date | Feb 10, 2026 |
About PetVivo Holdings
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota. [Read more]
Financial Performance
In 2024, PetVivo Holdings's revenue was $1.13 million, an increase of 16.91% compared to the previous year's $968,706. Losses were -$8.40 million, -23.33% less than in 2023.
Financial StatementsNews
PetVivo Holdings, Inc. Presenting at the 3rd Annual DealFlow Discovery Conference
MINNEAPOLIS, MN / ACCESS Newswire / December 23, 2025 / PetVivo Holdings, Inc. (OTCQX:PETV)(OTCID:PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, ...
PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore"
Revolutionary Veterinary AI Platform Ditches Dense Documentation in Favor of Clear, Engaging Video Walkthrough MINNEAPOLIS, MN, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PetVivo.ai, the AI powered platform tr...
UPDATED: PetVivo AI, Inc. Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-90%
Revolutionary PetVivo.ai Uses Nine AI Agents to Transform $150B Pet Care Market Important Disclaimer: This updated press release replaces and supersedes the version issued earlier this morning, which ...
PetVivo Holdings Inc (PETV) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic ...
PetVivo Holdings Inc (PETV) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Expansion Amidst Profitability Challenges
Q2 2026 PetVivo Holdings Inc Earnings Call Transcript
Q2 2026 PetVivo Holdings Inc Earnings Call Transcript
PetVivo Holdings, Inc. (PETV) Q2 2026 Earnings Call Transcript
PetVivo Holdings GAAP EPS of -$0.11, revenue of $0.3M
PetVivo Reports Fiscal Q2 2026 Results with Revenues up 50%
MINNEAPOLIS, MN, US, Nov. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company deli...
PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET
MINNEAPOLIS, MN, US, Nov. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and its wholly-owned subsidiary Petvivo Animal Health, Inc., a leading biomedical company deli...
Q1 2026 PetVivo Holdings Inc Earnings Call Transcript
Q1 2026 PetVivo Holdings Inc Earnings Call Transcript
Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors
MINNEAPOLIS, MN, US, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., both emerging bio...
PetVivo Animal Health Expands Veterinary Education with New RACE-Approved CE Courses on Osteoarthritis and Regenerative Therapies
On-demand programs deliver clinically relevant science, technical instruction, and case applications in small animal and equine practice
Petvivo Holdings, Inc. to Present at the Life Sciences Virtual Investor Forum September 18, 2025
MINNEAPOLIS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), working in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., (collectively "...
PetVivo Holdings GAAP EPS of -$0.09
PetVivo Holdings, Inc. (PETV) Q1 2026 Earnings Call Transcript
PetVivo Reports Fiscal Q1 2026 Results
MINNEAPOLIS, MN, US, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX: PETV; OTC ID: PETVW), a leading biomedical comp...
PetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ET
MINNEAPOLIS, MN, US, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equin...
PetVivo Holdings Inc. to Trade on OTCQX Best Market
MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX PETV; OTCID: PETVW) working in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetV...
PetVivo Holdings, Inc. (PETV) Q4 2025 Earnings Call Transcript
PetVivo Holdings GAAP EPS of -$0.39, revenue of $1.1M
PetVivo Reports Fiscal 2025 Results
MINNEAPOLIS, MN, US, June 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company de...
PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET
MINNEAPOLIS, MN, US, June 26, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines ...
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”...
PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
MINNEAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”...
PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing
Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), an emerging biomedical device company focused on animal health, today announced a strategic col...